Financial Data (All values in USD)
Year (FY) Earnings / Share Revenue Net Profit (cents) (mil) % Margin
2014 4 - 6c (est)
2013 6.60c 336.187 34.3% 2012 23.63c 292.141 125% *1-time gain 2011 3.88c 156.593 27.6% 2010 2.96c 116.179 27.5% 2009 (0.11)c 118.954 N.M 2008 (3.20)c 44.318 N.M 2007 (3.99)c 34.353 N.M
2006 (2.61)c 37.852 N.M
Other Data (as at Q1'2014 report)
Debt
- Current - 0.01 mil
- Total - 272.592 mil
Shares Issued - 1,710,959,000
Treasury Shares - 32,574,000
Options - 43,889,701
Div Payout - USD 0.02
Div period - July
NAV - 73.81c / SGD 0.90
Business Model
This company comprises of the following product group
- Critical care
- Interventional cardiology
- Cardiac Diagnostic
- Licensing & Royalty revenues
Biosensor since listed on SGX has been in the red for the inital 4 yrs before going into the profit region. However their earnings are inconsistent. But we can roughly gauge that they will have an earnings of 4 to 6 cents this year since their Q1'2014 has already been published on their website. I believe this company will be profitable this yr as they have expanded their capability to include Cardiac Diagnostic products.
Conclusion
This company is price at 97c on 12 Sept 2013. However, i believe this is the fair value for the company going forward. It would be great to accumulate if this counter can go below 88c.
DISCLAIMER The ideas expressed in this blog should not be used to buy or sell the securities, commodities or assets mentioned. The accuracy or completeness of the information provided cannot be guaranteed. Readers should carry out independent verification of information provided. No warranty whatsoever is given and no liability whatsoever is accepted for any loss howsoever arising whether directly or indirectly as a result of actions taken based on ideas and information found in this blog.
No comments:
Post a Comment